KG
AMRX icon

Kilter Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Kilter Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49K Sell
144
-22
-13% -$301 ﹤0.01% 933
2026
Q1 		$2.06K Hold
166
– – ﹤0.01% 937
2025
Q4 		$2.09K Buy
+166
New +$1.9K ﹤0.01% 771
2025
Q3 		– Sell
-22
Closed -$178 – 1220
2025
Q2 		$178 Buy
+22
New +$166 ﹤0.01% 1121

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kilter Group's AMRX Position: Q2 2026 in Review

Kilter Group reduced its Amneal Pharmaceuticals (AMRX) stake by 13% in Q2 2026, selling an estimated $301 and leaving 144 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

Kilter Group first reported a position in AMRX in Q2 2025 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Kilter Group held 144 shares of Amneal Pharmaceuticals worth $2.49K as of Q2 2026.
  • Kilter Group sold 22 Amneal Pharmaceuticals shares in Q2 2026, an estimated $301.
  • Amneal Pharmaceuticals made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #933 holding.
  • Kilter Group first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.